Results 161 to 170 of about 2,836,187 (243)

Aging analysis of latent fingerprint residues by tracking carotenoid and lipid degradation by Raman spectroscopy. [PDF]

Sci Rep
de Carvalho JPS, Santos AS, de Souza MA, da Silva SW.   +3 more
europepmc   +1 more source

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito, Chiara Meneghini, Alice Galli, Luca Gallo, Pierfrancesco Mitrotti, Paola Dimartino, Marianna Inglese, Cinzia Zatti, Alessandro Lupini, Andrea Pilotto, Alessandro Padovani, Micol Avenali, Enza Maria Valente, Cristina Tassorelli, Silvia P. Caminiti   +14 more
wiley   +1 more source

NIR photoresponse in the mixed phthalocyanine films

Open Physics, 2006
Pakhomov Geogrij, Kuzin Evgenij, Murel Arkadij   +2 more
doaj   +1 more source

DiNovo enables high-coverage and high-confidence de novo peptide sequencing via mirror proteases and deep learning. [PDF]

Nat Commun
Cao Z, Peng X, Zhang D, Zhou P, Kang L, Chi H, Wu R, Cheng Z, Zhang Y, Dai J, Li Y, Yao L, Li X, He Y, Yang J, Wang H, Xu P, Fu Y.   +17 more
europepmc   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang, Yixiu Pei, Xiaobao Hu, Ying Xiong, Fang Wang, Yanyan Yu, Min Zhu, Dandan Tan, Meihong Zhou, Daojun Hong, Fuqing Zhou   +10 more
wiley   +1 more source

Enhancing Veliparib PARP1 inhibitor stability against UVC degradation <i>via</i> DPPG liposome encapsulation. [PDF]

RSC Adv
Conceição CJF, Moe E, Ribeiro PA, Raposo M.   +3 more
europepmc   +1 more source

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Ultrafast dynamics in core-excited states probed by resonant Auger spectroscopy: pyrrole. [PDF]

Chem Sci
Holland DMP, McGhee HG, Lamanec M, Nachtigallová D, Milosavljević A, Bozek JD, Muchová E, Ingle RA.   +7 more
europepmc   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

A radio oval above Earth's auroral oval. [PDF]

Sci Adv
Wu S, Whiter DK, Lamy L, Taubenschuss U, Zarka P, Collet B, Wang X, Fischer G, Ning H, Chen Y, Wang M, Ye S, Yao Z, Kurth WS, Luan X.   +14 more
europepmc   +1 more source